Developer docs
API playgroundTry for free, no card

Search company profiles

New Jersey Harm Reduction Coalition

Full company profile

uuid004z8j4

Namestring
New Jersey Harm Reduction Coalition
Legal namestring
New Jersey Harm Reduction Coalition
Company typeenum
Private
Founded yearint
2019
Descriptiontext

New Jersey Harm Reduction Coalition (NJHRC) is a 501(c)-style nonprofit founded in 2019 and headquartered in Absecon, NJ, that operates the only statewide community naloxone distribution program in New Jersey as the state affiliate of NEXT Distro. The organization distributes naloxone (Narcan), fentanyl test strips, syringes, and safer-use supplies free of charge to New Jersey residents through mail-based delivery, a statewide phone/text line (1-877-4NARCAN), street outreach in New Brunswick, and a network of seven Harm Reduction Centers operated by partner organizations in Asbury Park, Atlantic City, Camden, Jersey City, Newark, Paterson, and Trenton. NJHRC also offers customized organizational training and technical assistance on a sliding-scale basis, conducts community-driven research, and leads statewide advocacy on naloxone access, syringe access, and drug decriminalization, including co-signing testimony to NJ's Opioid Settlement Advisory Council.

NJHRC's business model is donation- and grant-funded: harm reduction supplies are provided at zero price to end users, while supplemental revenue comes from individual donations processed via Action Network and sliding-scale fees for organizational training. The organization grew from an all-volunteer operation operating out of living rooms into a professionally staffed team of ten by 2023, with documented operational scale of more than 10,000 naloxone doses distributed and at least 140 overdose reversals reported in 2023. Strategic partners include the NJ Department of Health, NEXT Distro, ACLU-NJ, NJ Policy Perspective, and Newark Community Street Team, alongside harm reduction service providers VNACJ, South Jersey AIDS Alliance, Camden AHEC, Hyacinth Foundation, and NJCRI. Leadership is provided by co-founder and Executive Director Jenna Mellor, who also serves on NJ's Opioid Recovery and Remediation Advisory Council, under a feminist co-director governance model.

The underlying 'technology' stack is operational rather than digital: a mail-based fulfillment system operating under NEXT Distro, a confidential intake line, an Action Network email and donation platform, and community-distributor logistics. Revenue is concentrated in unrestricted giving, foundation grants, and advocacy-driven public funding (notably opioid settlement dollars), with no venture, parent, or for-profit ownership and no disclosed financials.

Short descriptiontext

New Jersey Harm Reduction Coalition is a New Jersey nonprofit founded in 2019 that distributes free naloxone, fentanyl test strips, syringes, and safer-use supplies statewide as the NJ affiliate of NEXT Distro, while running training, street outreach, and drug-policy advocacy for people who use drugs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAbsecon, United States
HQ citystring
Absecon
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
harm reduction services, naloxone distribution, syringe access programs, overdose prevention supplies, drug user health support
Industry4 codes
1Substance Use Recovery & Harm Reduction Support Services
CodeBPAGAEAOPrimaryYes
2Substance Use Disorder Prevention & Recovery Services
CodeBPAGACAEPrimaryNo
3Substance Use, Addiction & Harm Reduction Health Departments
CodeHLAJAAAMPrimaryNo
4Pollution Prevention & Toxics Reduction
CodeBPAGAGAJPrimaryNo
NAICS code2 codes
  • Outpatient Mental Health and Substance Abuse Centers621420
  • Voluntary Health Organizations813212
SIC code1 code
  • Sanitary Services4950
Product category
Harm Reduction Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Grants and Donations
TypeProfessional Services
Description

NJHRC operates as a nonprofit organization funded primarily through grants, donations, and potentially opioid settlement funds. Services are provided free of charge to residents. The organization accepts donations through Action Network.

njharmreduction.org
2Training and Technical Assistance (fee-for-service)
TypeProfessional Services
Description

Offers customized organizational trainings on a sliding-scale basis, where organizations with larger budgets can subsidize trainings for organizations with smaller budgets or mutual aid groups.

njharmreduction.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
Pricing details1 tier
1Free naloxone and harm reduction supplies for NJ residents
ModelFreemiumBilling cadencePay-as-you-go
Notes

Naloxone (brand name Narcan) is mailed for free and confidentially throughout New Jersey. Fentanyl test strips are also mailed for free. Available to anyone in NJ who requests it, prioritizing those most likely to witness an overdose.

njharmreduction.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

New Jersey Harm Reduction Coalition distributes free harm reduction supplies — including naloxone (Narcan), sterile syringes, and fentanyl test strips — to people who use drugs statewide in New Jersey through mail order and seven Harm Reduction Centers. The organization also conducts street outreach and provides training, technical assistance, and policy advocacy to expand access to overdose prevention and drug user health services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 10,000 naloxone doses distributed with at least 140 documented overdose reversals in 2023 alone
+1 more record
Product overview1 text field

New Jersey Harm Reduction Coalition operates a multi-component harm reduction service portfolio centered on overdose prevention and drug user health. Core offerings include free naloxone distribution via mail and seven Harm Reduction Centers statewide, fentanyl test strips, and safer use supplies. These services are delivered alongside training and technical assistance for organizations, street outreach, policy advocacy, and community-driven research. The organization serves as the state affiliate of NEXT Distro for mail-based services.

Product and service1 record
1Mail-Order Harm Reduction Supplies
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

NJHRC serves as the state affiliate of NEXT Distro, operating the mail-based harm reduction supply distribution program. NEXT Distro is a national online and mail-based harm reduction service that enables NJHRC to distribute naloxone and fentanyl test strips throughout New Jersey.

2Visiting Nurse Association of Central Jersey — Prevention Resource Network
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Operates the Harm Reduction Center in Asbury Park, NJ, one of seven HRCs in the state. Provides syringe access, safer injection supplies, naloxone, and connections to resources.

njharmreduction.org
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Operates the Harm Reduction Center in Atlantic City, NJ. Provides harm reduction services including syringe access and naloxone distribution.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Operates the mobile Harm Reduction Center in Camden, NJ. Provides harm reduction services through a mobile site.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Operates Harm Reduction Centers in Jersey City, Paterson, and Trenton, NJ. One of the primary harm reduction service providers in the state network.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Operates the Harm Reduction Center in Newark, NJ. Provides harm reduction services including syringe access, naloxone, and connections to healthcare and social services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborating with NJDOH to distribute supplies to overdose hotspots and on a statewide communications campaign about mail-based naloxone and syringe access. NJDOH issues the statewide standing order for naloxone distribution and regulates syringe access programs.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Collaborates with local grassroots and mutual aid groups for weekly street outreach in New Brunswick and pop-up overdose education and naloxone distribution events.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Partner to integrate naloxone distribution into regular outreach or participant services. Provides naloxone for every participant to take-home.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Partner to provide naloxone for residents leaving treatment or recovery programs who are at high risk of overdose.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Co-signed testimony to NJ Opioid Settlement Advisory Council on investing settlement funds in public health approach. Collaborates on drug policy reform advocacy.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Co-signed testimony and advocacy letters on drug policy reform, opioid settlement fund investment, and harm reduction expansion.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Co-signed advocacy letters and collaborates on harm reduction and drug policy reform efforts statewide.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest U.S. drug-policy reform organization. NJHRC emerged in 2019 after the closure of DPA's NJ affiliate and continues DPA-aligned advocacy on drug decriminalization, harm reduction, and opioid settlement fund allocation.

TypeDirect peer
Description

National online and mail-based harm reduction service. NJHRC is the New Jersey state affiliate of NEXT Distro and operates the same mail-based naloxone distribution model NEXT Distro pioneered, making it the closest functional peer.

TypeDirect peer
Description

Long-running, lived-experience-led harm reduction organization in New York. Operates similar syringe access, overdose prevention, and peer-delivered supply services in an adjacent Northeast geography.

TypeDirect peer
Description

Operates Harm Reduction Centers in Jersey City, Paterson, and Trenton as a direct NJHRC channel partner. Delivers syringe access, naloxone distribution, and connections to care for PWUD in NJ.

TypeDirect peer
Description

Operates the Atlantic City Harm Reduction Center as an NJHRC partner organization. Delivers needle exchange and harm reduction services to PWUD in southern NJ.

TypeDirect peer
Description

National harm reduction advocacy and capacity-building organization. NJHRC operates a similar lived-experience-led, syringe-access- and naloxone-focused portfolio and participates in the same advocacy networks, making it a peer in mission and operating model.

7Visiting Nurse Association of Central Jersey — Prevention Resource Network
TypeDirect peer
Description

Operates the Asbury Park Harm Reduction Center as an NJHRC partner. Provides the same syringe access, safer injection supplies, and naloxone distribution services in NJ.

TypeOthers
Description

Strategic advocacy partner rather than operational peer. NJHRC's board chair is an ACLU-NJ campaign strategist, and the two organizations co-sign opioid-settlement and drug-policy reform advocacy.

TypeDirect peer
Description

Operates the Newark Harm Reduction Center as a direct NJHRC partner. Provides the same syringe access, naloxone, and HIV/HCV testing services to people who use drugs in NJ, making it a same-state operational peer.

TypeDirect peer
Description

Operates the mobile Harm Reduction Center in Camden as an NJHRC partner. Provides community-based harm reduction services in southern NJ.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

New Jersey Harm Reduction Coalition

Harm Reduction Servicesnjharmreduction.org

New Jersey Harm Reduction Coalition is a New Jersey nonprofit founded in 2019 that distributes free naloxone, fentanyl test strips, syringes, and safer-use supplies statewide as the NJ affiliate of NEXT Distro, while running training, street outreach, and drug-policy advocacy for people who use drugs.

What New Jersey Harm Reduction Coalition does

New Jersey Harm Reduction Coalition (NJHRC) is a 501(c)-style nonprofit founded in 2019 and headquartered in Absecon, NJ, that operates the only statewide community naloxone distribution program in New Jersey as the state affiliate of NEXT Distro. The organization distributes naloxone (Narcan), fentanyl test strips, syringes, and safer-use supplies free of charge to New Jersey residents through mail-based delivery, a statewide phone/text line (1-877-4NARCAN), street outreach in New Brunswick, and a network of seven Harm Reduction Centers operated by partner organizations in Asbury Park, Atlantic City, Camden, Jersey City, Newark, Paterson, and Trenton. NJHRC also offers customized organizational training and technical assistance on a sliding-scale basis, conducts community-driven research, and leads statewide advocacy on naloxone access, syringe access, and drug decriminalization, including co-signing testimony to NJ's Opioid Settlement Advisory Council.

NJHRC's business model is donation- and grant-funded: harm reduction supplies are provided at zero price to end users, while supplemental revenue comes from individual donations processed via Action Network and sliding-scale fees for organizational training. The organization grew from an all-volunteer operation operating out of living rooms into a professionally staffed team of ten by 2023, with documented operational scale of more than 10,000 naloxone doses distributed and at least 140 overdose reversals reported in 2023. Strategic partners include the NJ Department of Health, NEXT Distro, ACLU-NJ, NJ Policy Perspective, and Newark Community Street Team, alongside harm reduction service providers VNACJ, South Jersey AIDS Alliance, Camden AHEC, Hyacinth Foundation, and NJCRI. Leadership is provided by co-founder and Executive Director Jenna Mellor, who also serves on NJ's Opioid Recovery and Remediation Advisory Council, under a feminist co-director governance model.

The underlying 'technology' stack is operational rather than digital: a mail-based fulfillment system operating under NEXT Distro, a confidential intake line, an Action Network email and donation platform, and community-distributor logistics. Revenue is concentrated in unrestricted giving, foundation grants, and advocacy-driven public funding (notably opioid settlement dollars), with no venture, parent, or for-profit ownership and no disclosed financials.

New Jersey Harm Reduction Coalition firmographics

Firmographics
Name
New Jersey Harm Reduction Coalition
Legal name
New Jersey Harm Reduction Coalition
Website
https://njharmreduction.org
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
New Jersey Harm Reduction Coalition is a New Jersey nonprofit founded in 2019 that distributes free naloxone, fentanyl test strips, syringes, and safer-use supplies statewide as the NJ affiliate of NEXT Distro, while running training, street outreach, and drug-policy advocacy for people who use drugs.
Ownership category
akta.pro rank

New Jersey Harm Reduction Coalition industry classification

Industry
Product category
Harm Reduction Services
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420), Voluntary Health Organizations (813212)
SIC
Sanitary Services (4950)
akta.pro primary industry
Substance Use Recovery & Harm Reduction Support Services (BPAGAEAO)
akta.pro secondary industries
Substance Use Disorder Prevention & Recovery Services (BPAGACAE), Substance Use, Addiction & Harm Reduction Health Departments (HLAJAAAM), Pollution Prevention & Toxics Reduction (BPAGAGAJ)

Keywords

  • Harm reduction services
  • Naloxone distribution
  • Syringe access programs
  • Overdose prevention supplies
  • Drug user health support

Where New Jersey Harm Reduction Coalition is headquartered

Location

Headquarters

HQ city
Absecon
HQ country
United States
HQ region
North America

Offices9 records

Markets served

New Jersey Harm Reduction Coalition business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. Grants and Donations: NJHRC operates as a nonprofit organization funded primarily through grants, donations, and potentially opioid settlement funds. Services are provided free of charge to residents. The organization accepts donations through Action Network.
  2. Training and Technical Assistance (fee-for-service): Offers customized organizational trainings on a sliding-scale basis, where organizations with larger budgets can subsidize trainings for organizations with smaller budgets or mutual aid groups.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree naloxone and harm reduction supplies for NJ residents

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

New Jersey Harm Reduction Coalition product offering

Product offering

Core offering

New Jersey Harm Reduction Coalition distributes free harm reduction supplies — including naloxone (Narcan), sterile syringes, and fentanyl test strips — to people who use drugs statewide in New Jersey through mail order and seven Harm Reduction Centers. The organization also conducts street outreach and provides training, technical assistance, and policy advocacy to expand access to overdose prevention and drug user health services.

Product overview

New Jersey Harm Reduction Coalition operates a multi-component harm reduction service portfolio centered on overdose prevention and drug user health. Core offerings include free naloxone distribution via mail and seven Harm Reduction Centers statewide, fentanyl test strips, and safer use supplies. These services are delivered alongside training and technical assistance for organizations, street outreach, policy advocacy, and community-driven research. The organization serves as the state affiliate of NEXT Distro for mail-based services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Mail-Order Harm Reduction Supplies

Quantifiable outcome

  • Over 10,000 naloxone doses distributed with at least 140 documented overdose reversals in 2023 alone
  • +1 more outcomes

Companies that use New Jersey Harm Reduction Coalition

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles2 records

New Jersey Harm Reduction Coalition technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

New Jersey Harm Reduction Coalition partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and major.

  • NEXT DistrocoreStrategic or Co-development Partner · 1 January 2019NJHRC serves as the state affiliate of NEXT Distro, operating the mail-based harm reduction supply distribution program. NEXT Distro is a national online and mail-based harm reduction service that enables NJHRC to distribute naloxone and fentanyl test strips throughout New Jersey.
  • Visiting Nurse Association of Central Jersey — Prevention Resource NetworkcoreChannel Partner/ Reseller/ DistributorOperates the Harm Reduction Center in Asbury Park, NJ, one of seven HRCs in the state. Provides syringe access, safer injection supplies, naloxone, and connections to resources.
  • South Jersey AIDS AlliancecoreChannel Partner/ Reseller/ DistributorOperates the Harm Reduction Center in Atlantic City, NJ. Provides harm reduction services including syringe access and naloxone distribution.
  • Camden Area Health Education Center (Camden AHEC)coreChannel Partner/ Reseller/ DistributorOperates the mobile Harm Reduction Center in Camden, NJ. Provides harm reduction services through a mobile site.
  • Hyacinth FoundationcoreChannel Partner/ Reseller/ DistributorOperates Harm Reduction Centers in Jersey City, Paterson, and Trenton, NJ. One of the primary harm reduction service providers in the state network.
  • North Jersey Community Research Initiative (NJCRI)coreChannel Partner/ Reseller/ DistributorOperates the Harm Reduction Center in Newark, NJ. Provides harm reduction services including syringe access, naloxone, and connections to healthcare and social services.
  • New Jersey Department of HealthcoreStrategic or Co-development PartnerCollaborating with NJDOH to distribute supplies to overdose hotspots and on a statewide communications campaign about mail-based naloxone and syringe access. NJDOH issues the statewide standing order for naloxone distribution and regulates syringe access programs.
  • Grassroots and Mutual Aid GroupsmajorChannel Partner/ Reseller/ DistributorCollaborates with local grassroots and mutual aid groups for weekly street outreach in New Brunswick and pop-up overdose education and naloxone distribution events.
  • In-patient Treatment ProgramsmajorChannel Partner/ Reseller/ DistributorPartner to integrate naloxone distribution into regular outreach or participant services. Provides naloxone for every participant to take-home.
  • Recovery Housing ProgramsmajorChannel Partner/ Reseller/ DistributorPartner to provide naloxone for residents leaving treatment or recovery programs who are at high risk of overdose.
  • ACLU of New JerseymajorStrategic or Co-development PartnerCo-signed testimony to NJ Opioid Settlement Advisory Council on investing settlement funds in public health approach. Collaborates on drug policy reform advocacy.
  • New Jersey Policy PerspectivemajorStrategic or Co-development PartnerCo-signed testimony and advocacy letters on drug policy reform, opioid settlement fund investment, and harm reduction expansion.
  • Newark Community Street TeammajorStrategic or Co-development PartnerCo-signed advocacy letters and collaborates on harm reduction and drug policy reform efforts statewide.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

New Jersey Harm Reduction Coalition competitors and assessment

Company assessment

Broad incumbents

  • Drug Policy Alliance: Largest U.S. drug-policy reform organization. NJHRC emerged in 2019 after the closure of DPA's NJ affiliate and continues DPA-aligned advocacy on drug decriminalization, harm reduction, and opioid settlement fund allocation.

Direct peers

  • NEXT Distro: National online and mail-based harm reduction service. NJHRC is the New Jersey state affiliate of NEXT Distro and operates the same mail-based naloxone distribution model NEXT Distro pioneered, making it the closest functional peer.
  • New York Harm Reduction Educators (NYHRE): Long-running, lived-experience-led harm reduction organization in New York. Operates similar syringe access, overdose prevention, and peer-delivered supply services in an adjacent Northeast geography.
  • Hyacinth Foundation: Operates Harm Reduction Centers in Jersey City, Paterson, and Trenton as a direct NJHRC channel partner. Delivers syringe access, naloxone distribution, and connections to care for PWUD in NJ.
  • South Jersey AIDS Alliance: Operates the Atlantic City Harm Reduction Center as an NJHRC partner organization. Delivers needle exchange and harm reduction services to PWUD in southern NJ.
  • National Harm Reduction Coalition: National harm reduction advocacy and capacity-building organization. NJHRC operates a similar lived-experience-led, syringe-access- and naloxone-focused portfolio and participates in the same advocacy networks, making it a peer in mission and operating model.
  • Visiting Nurse Association of Central Jersey — Prevention Resource Network: Operates the Asbury Park Harm Reduction Center as an NJHRC partner. Provides the same syringe access, safer injection supplies, and naloxone distribution services in NJ.
  • North Jersey Community Research Initiative (NJCRI): Operates the Newark Harm Reduction Center as a direct NJHRC partner. Provides the same syringe access, naloxone, and HIV/HCV testing services to people who use drugs in NJ, making it a same-state operational peer.
  • Camden Area Health Education Center (Camden AHEC): Operates the mobile Harm Reduction Center in Camden as an NJHRC partner. Provides community-based harm reduction services in southern NJ.

Others

  • ACLU of New Jersey: Strategic advocacy partner rather than operational peer. NJHRC's board chair is an ACLU-NJ campaign strategist, and the two organizations co-sign opioid-settlement and drug-policy reform advocacy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

New Jersey Harm Reduction Coalition social profiles

Digital presence

New Jersey Harm Reduction Coalition financial estimates

Financial estimate

Revenue estimate

Valuation estimate

New Jersey Harm Reduction Coalition leadership team

Management profile

Number of profiles

New Jersey Harm Reduction Coalition funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

New Jersey Harm Reduction Coalition M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New Jersey Harm Reduction Coalition

What does New Jersey Harm Reduction Coalition do?

New Jersey Harm Reduction Coalition distributes free harm reduction supplies — including naloxone (Narcan), sterile syringes, and fentanyl test strips — to people who use drugs statewide in New Jersey through mail order and seven Harm Reduction Centers. The organization also conducts street outreach and provides training, technical assistance, and policy advocacy to expand access to overdose prevention and drug user health services.

Is New Jersey Harm Reduction Coalition a public or private company?

New Jersey Harm Reduction Coalition is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was New Jersey Harm Reduction Coalition founded?

New Jersey Harm Reduction Coalition was founded in 2019. It employs 1 to 10 people.

Where is New Jersey Harm Reduction Coalition based?

New Jersey Harm Reduction Coalition is headquartered in Absecon, United States, in the North America region.

How does New Jersey Harm Reduction Coalition make money?

Two revenue lines are on record. Grants and Donations are the primary driver. The others are training and Technical Assistance (fee-for-service).

Who are New Jersey Harm Reduction Coalition's main competitors?

Drug Policy Alliance is listed as a broad incumbent. Direct peers are NEXT Distro, New York Harm Reduction Educators (NYHRE), Hyacinth Foundation, South Jersey AIDS Alliance, National Harm Reduction Coalition, Visiting Nurse Association of Central Jersey — Prevention Resource Network, North Jersey Community Research Initiative (NJCRI) and Camden Area Health Education Center (Camden AHEC). ACLU of New Jersey is listed as an others.

Does New Jersey Harm Reduction Coalition have an API?

No public API is recorded for New Jersey Harm Reduction Coalition.

What industry is New Jersey Harm Reduction Coalition in?

New Jersey Harm Reduction Coalition's product category is Harm Reduction Services. Its primary akta.pro industry code is BPAGAEAO, Substance Use Recovery & Harm Reduction Support Services, with a secondary code of BPAGACAE, Substance Use Disorder Prevention & Recovery Services. Its NAICS code is 621420 and its SIC code is 4950.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales